A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells

This publication has 39 references indexed in Scilit:

• Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy
  Bioorganic & Medicinal Chemistry, 2005
• Antiangiogenic photodynamic therapy (PDT) by using long-circulating liposomes modified with peptide specific to angiogenic vessels
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 2005
• Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer
  British Journal of Cancer, 2005
• Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
  Endocrine Reviews, 2004
• Targeted photodynamic therapy via receptor mediated delivery systems
  Advanced Drug Delivery Reviews, 2003
• Vascular endothelial growth factor (VEGF) and its receptors
  The FASEB Journal, 1999
• Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer
  British Journal of Cancer, 1998
• Photodynamic Therapy
  JNCI Journal of the National Cancer Institute, 1998
• Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor
  Cell, 1998
• Angiogenesis in cancer, vascular, rheumatoid and other disease
  Nature Medicine, 1995